Treatment of hepatocellular carcinoma with intra-arterial injection of radionuclides (Q37669167)

21 August 2017

1 reference

title

Treatment of hepatocellular carcinoma with intra-arterial injection of radionuclides (English)

1 reference

21 August 2017

main subject

hepatocellular carcinoma

1 reference

Jean-Luc Raoul

1 reference

21 August 2017

Eveline Boucher

series ordinal

1 reference

21 August 2017

Yan Rolland

series ordinal

1 reference

21 August 2017

Etienne Garin

series ordinal

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 January 2010

1 reference

Nature Reviews Gastroenterology & Hepatology

21 August 2017

published in

1 reference

21 August 2017

1 reference

21 August 2017

1 reference

21 August 2017

page(s)

41-49

1 reference

Hepatic artery injection of I-131-labeled lipiodol. Part II. Preliminary results of therapeutic use in patients with hepatocellular carcinoma and liver metastases

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Adjuvant lipiodol I-131 after curative resection/ablation of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Intra-arterial rhenium-188 lipiodol in the treatment of inoperable hepatocellular carcinoma: results of an IAEA-sponsored multination study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Primary liver cancer: worldwide incidence and trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Time trends and age-period-cohort effects on the incidence of primary liver cancer in a well-defined French population: 1976-1995.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Trends in mortality from hepatocellular carcinoma in Europe, 1980-2004.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Prognosis of advanced hepatocellular carcinoma: comparison of three staging systems in two French clinical trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

31 March 2020

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Escalated Focal Liver Radiation and Concurrent Hepatic Artery Fluorodeoxyuridine for Unresectable Intrahepatic Malignancies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Design and endpoints of clinical trials in hepatocellular carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Drug-eluting particles in the treatment of HCC: chemoembolization with doxorubicin-loaded DC Bead

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Regional radioactive treatments for hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

188Re-SSS lipiodol: radiolabelling and biodistribution following injection into the hepatic artery of rats bearing hepatoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Radioembolization with 90Y microspheres: technical considerations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Hepatic artery injection of I-131-labeled lipiodol. Part I. Biodistribution study results in patients with hepatocellular carcinoma and liver metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Treatment of hepatocellular carcinoma by means of radiopharmaceuticals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Dosimetric evaluation and therapeutic response to internal radiation therapy of hepatocarcinomas using iodine-131-labelled lipiodol.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Internal radiation therapy for hepatocellular carcinoma. Results of a french multicenter phase II trial of transarterial injection of iodine 131-labeled lipiodol

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Usefulness of Hepatic Artery Injection of Iodized Oil and131I-Labeled Iodized Oil before the Therapeutic Decision in Hepatocellular Carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Hepatic intraarterial 131I iodized oil for treatment of hepatocellular carcinoma in patients with impeded portal venous flow

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Adjuvant intra-arterial iodine-131-labeled lipiodol for resectable hepatocellular carcinoma: a prospective randomized trial-update on 5-year and 10-year survival

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Adjuvant intra-arterial injection of iodine-131-labeled lipiodol after resection of hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Adjuvant intraarterial injection of 131I-labeled lipiodol after resection of hepatocellular carcinoma: progress report of a case-control study with a 5-year minimal follow-up

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Adjuvant iodine-131-labeled lipiodol for prevention of intrahepatic recurrence of hepatocellular carcinoma: which is the best treatment schedule?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Resection of hepatocellular carcinoma in noncirrhotic liver: analysis of risk factors for survival

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Preoperative treatment of hepatocellular carcinoma with intra-arterial injection of 131I-labelled lipiodol

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Acute toxicity of lipiodol infusion into the hepatic arteries of dogs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Safe radiation exposure of medical personnel by using simple methods of radioprotection while administering 131I-lipiodol therapy for hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Inoperable hepatocellular carcinoma: transarterial 188Re HDD-labeled iodized oil for treatment--prospective multicenter clinical trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

A phase I dose escalation trial of yttrium-90 microspheres in the treatment of primary hepatocellular carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Locoregional treatment for hepatocellular carcinoma: From clinical exploration to robust clinical data, changing standards of care

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Radiologic-pathologic correlation of hepatocellular carcinoma treated with internal radiation using yttrium-90 microspheres

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Salvage surgery following downstaging of unresectable hepatocellular carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Association of cisplatin and intra-arterial injection of 131I-lipiodol in treatment of hepatocellular carcinoma: results of phase II trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Treatment of fluorouracil-refractory patients with liver metastases from colorectal cancer by using yttrium-90 resin microspheres plus concomitant systemic irinotecan chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

The promise of locoregional radiopharmaceutical therapy: will it ever be realized?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.202

Yttrium-90 labelled resin microspheres for treatment of primary and secondary malignant liver tumors

31 March 2020

1 reference

12 December 2020

Sorafenib in advanced hepatocellular carcinoma

1 reference

12 December 2020

Dosimetry of iodine-131 ethiodol in the treatment of hepatoma

1 reference

12 December 2020

Gastroduodenitis associated with yttrium 90-microsphere selective internal radiation: an iatrogenic complication in need of recognition

1 reference

12 December 2020

Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations.

1 reference

12 December 2020

Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support

1 reference

12 December 2020

188Re-HDD/lipiodol therapy for hepatocellular carcinoma: a phase I clinical trial.

1 reference

12 December 2020

Prospective randomized trial of chemoembolization versus intra-arterial injection of 131I-labeled-iodized oil in the treatment of hepatocellular carcinoma

1 reference

12 December 2020

Intra-arterial injection of iodine-131-labeled lipiodol for treatment of hepatocellular carcinoma

1 reference

12 December 2020

In vitro demonstration of synergy between radionuclide and chemotherapy

1 reference

12 December 2020

10.1038/NRGASTRO.2009.202

Identifiers

DOI

1 reference

release_774saemv4nhy5ihe3pczg3d3yu

21 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/774saemv4nhy5ihe3pczg3d3yu

24 November 2022

mapped directly with Wikidata item

1 reference